Shan Peng

机构：Nanfang Hospital, Southern Medical University · ORCID：0000-0002-4432-6008

发表论文 16 篇 · 总被引 130 次 · h-index 5

代表论文

• Multi-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer (2024 · Molecular Cancer · 被引 45)
• A Deletion Upstream of SOX10 Causes Light Yellow Plumage Colour in Chicken (2022 · Genes · 被引 30)
• The Value of 68 Ga-PSMA PET/MRI for Classifying Patients with PI-RADS 3 Lesions on Multiparametric MRI: A Prospective Single-Center Study (2024 · Journal of Nuclear Medicine · 被引 19)
• The Association Between [ 68 Ga]PSMA PET/CT Response and Biochemical Progression in Patients with High-Risk Prostate Cancer Receiving Neoadjuvant Therapy (2023 · Journal of Nuclear Medicine · 被引 11)
• HDAC2 as a therapeutic target in bladder cancer: insights into the altered epigenetic regulation and lysine lactylation (2025 · Journal of Experimental & Clinical Cancer Research · 被引 8)
• Pathological and radiological features of false-positive lesions on [68Ga]Ga-PSMA-11 PET/CT in primary staging of prostate cancer: a radio-pathology matching analysis (2025 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 5)